ROIVANT SCIENCES LTD. Lessee, Operating Lease, Discount Rate
ROIVANT SCIENCES LTD. (ROIV) had Lessee, Operating Lease, Discount Rate of 8.50% as of 2025-12-31, per its 10-K filed 2026-05-20.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseDiscountRate · last filed 2026-05-20
- 2025-12-31: Lessee, Operating Lease, Discount Rate 8.50%.
| Period end | Lessee, Operating Lease, Discount Rate |
|---|---|
| 2025-12-31 | 8.50% 10-K · filed 2026-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |